```

[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[H.R. 315 Introduced in House (IH)]

113th CONGRESS
  1st Session
                                H. R. 315

 To provide for the placement of certain synthetic drugs on Schedule I 
                  under the Controlled Substances Act.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 18, 2013

 Mrs. Emerson introduced the following bill; which was referred to the 
 Committee on Energy and Commerce, and in addition to the Committee on 
   the Judiciary, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL

 
 To provide for the placement of certain synthetic drugs on Schedule I 
                  under the Controlled Substances Act.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Synthetic Cathinones Control Act of 
2013''.

SEC. 2. ADDITION OF SYNTHETIC DRUGS TO SCHEDULE I OF THE CONTROLLED 
              SUBSTANCES ACT.

    (a) In General.--Notwithstanding any other provision of the 
Controlled Substances Act (21 U.S.C. 801 et seq.), the Attorney General 
shall, not later than 60 days after the date of the enactment of this 
Act, issue a final order that schedules the following substances on 
schedule I under section 202(c) of that Act (21 U.S.C. 812(c)):
            (1) 3,4-methylenedioxymethcathinone (methylone).
            (2) Naphthylpyrovalerone (naphyrone).
            (3) 4-fluoromethcathinone (flephedrone).
            (4) 4-methoxymethcathinone (methedrone; Bk-PMMA).
            (5) Ethcathinone (N-ethylcathinone).
            (6) 3,4-methylenedioxyethcathinone (ethylone).
            (7) Beta-keto-N-methyl-3,4-benzodioxyolybutanamine 
        (butylone).
            (8) N,N-dimethylcathinone (metamfepramone).
            (9) Alpha-pyrrolidinopropiophenone (alpha-PPP).
            (10) 4-methoxy-alphapyrrolidinopropiophenone (MOPPP).
            (11) 3,4-methylenedioxyalphapyrrolidinopropiophenone 
        (MDPPP).
            (12) Alpha-pyrrolidinovalerophenone (alpha-PVP).
            (13) 6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine 
        (MDAI).
            (14) 3-fluoromethcathinone.
            (15) 4'-methyl-a-pyrrolidinobutiophenone (MPBP).
    (b) Conforming Amendment To Remove Deadwood.--Subsection (c) of 
section 202 of the Controlled Substances Act (21 U.S.C. 802) is amended 
to read as follows:
    ``(c) Cross Reference to Schedules of Controlled Substances.--
Schedules I, II, III, IV, and V shall consist of the drugs and other 
substances (by whatever official name, common or usual name, chemical 
name, or brand name designated) that are set forth in the respective 
schedules in part 1308 of title 21, Code of Federal Regulations, as 
they may be amended from time to time, or in any successor 
regulation.''.
                                 <all>
```